Tobacco.org

Nordic scientists start trial on nicotine vaccine 

Nordic scientists have launched a trial on a vaccine designed to help smokers kick the world's deadliest habit by depriving them of one of its chief pleasures, the firm that owns the vaccine said on Tuesday.

Independent Pharmaceutica, a private company based at Stockholm's Karolinska Institute and founded in 1997 by Professor Torgny Svensson, joins a growing line-up of biotech companies seeking to develop an anti-nicotine shot.

Its researchers say the vaccine eliminates the quick high smokers relish by creating antibodies that bind to nicotine molecules, making them too bulky to enter the brain.

Jump to full article »